Advertisement.

INBX Projected Dividend Yield

Inhibrx Biosciences Inc ( NASDAQ : INBX )

Inhibrx is a clinical-stage biotechnology company with a pipeline of biologic therapeutic candidates, developed using its protein engineering expertise and proprietary single domain antibody, or sdAb, platform. Co.'s sdAb platform allows it to pursue validated targets with clinical promise, but where other antibody and biologic based approaches have failed. Co.'s existing pipeline is focused on oncology and orphan diseases. Co. has four programs in ongoing clinical trials. Three of these programs are for the treatment of various cancers, and one for the treatment of Alpha-1 Antitrypsin Deficiency. Co.'s pipelines include: INBRX-10, INBRX-109, INBRX-106, and INBRX-105.

20 YEAR PERFORMANCE RESULTS

INBX Dividend History Detail
INBX Dividend News
INBX Competitors News

# of Shares: 0

Closing Price: 14.62

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000